Unjha Formulations Share Price | Unjha Formulations Stock Screener
UNJHAFOR
Pharmaceuticals
Share Price BSE
₹18.55
▼
-0.45 (-2.37%)
As of July 3, 2026, the Unjha Formulations share price (BSE: UNJHAFOR) is ₹18.55, down 2.37% from the previous close, with shares trading between ₹18.55 and ₹21.68, and a 52-week range of ₹17.55–₹28.85.
Analyse UNJHAFOR share price history and track historical price performance.
Use the Unjha Formulations stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Unjha Formulations Market Cap
₹8.28 Cr.
UNJHAFOR P/E Ratio (TTM)
12.10
Unjha Formulations P/B Ratio
2.22
EPS (TTM)
₹1.57
Dividend Yield
-
Debt to Equity
-
UNJHAFOR 52 Week High
₹28.85
Unjha Formulations 52 Week Low
₹17.55
Operating Margin
6.00%
Profit Margin
6.25%
UNJHAFOR Revenue (TTM)
₹16.00
EBITDA
₹1.00
Net Income
₹1.00
Total Assets
₹6.00
Total Equity
₹4.00
Unjha Formulations Share Price Chart
Screen Unjha Formulations share price with an interactive chart. Analyse UNJHAFOR price trends and volatility across different timeframes.
Unjha Formulations Company Profile - Fundamental Screener
Screen Unjha Formulations company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for UNJHAFOR shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE576D01015
Unjha Formulations Balance Sheet Screener
Screen UNJHAFOR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 6 | 5 | 5 | 3 | 4 | 4 | 4 | 4 | 4 | 4 |
| Current Assets | 4 | 3 | 4 | 2 | 2 | 2 | 3 | 3 | 3 | 2 |
| Fixed Assets | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 4 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 1 | 1 |
| Share Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves & Surplus | -1 | -1 | -2 | -2 | -2 | -3 | -3 | -3 | -3 | -4 |
Unjha Formulations Income Statement Screener - Profit & Revenue Analysis
Screen Unjha Formulations income statement and profit fundamentals.
Analyze UNJHAFOR quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Unjha Formulations share price evaluation.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 16 | 14 | 19 | 13 | 14 | 10 | 11 | 12 | 11 | 12 | 10 | 9 |
| Expenses | 15 | 13 | 18 | 13 | 14 | 10 | 10 | 11 | 11 | 12 | 10 | 9 |
| EBITDA | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 |
| Operating Profit % | 6.00% | 4.00% | 3.00% | 3.00% | 2.00% | 1.00% | 2.00% | 3.00% | 3.00% | 3.00% | 4.00% | 2.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS | 1.57 | 0.91 | 0.62 | 0.63 | 0.56 | 0.23 | 0.69 | 0.67 | 0.59 | 0.66 | 0.57 | 0.39 |
Unjha Formulations Cash Flow Screener - Liquidity Fundamentals
Screen UNJHAFOR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 0 | 1 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 1 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 |
Unjha Formulations Shareholding Pattern Screener
See Unjha Formulations shareholding pattern with promoter, FII, and DII holdings.
Check Unjha Formulations promoter holding and ownership changes for UNJHAFOR on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 36.92% | 36.92% | 36.92% | 36.92% | 36.92% | 36.92% | 36.92% | 36.92% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 55.53% | 56.80% | 56.10% | 56.19% | 56.14% | 58.13% | 57.78% | 56.90% |
| Other Holding | 7.54% | 6.28% | 6.98% | 6.88% | 6.94% | 4.95% | 5.30% | 6.17% |
| Shareholder Count | 4,235 | 4,273 | 4,213 | 4,284 | 4,251 | 3,933 | 3,985 | 3,969 |
Unjha Formulations Share Dividend Screener - Share Yield Analysis
Check Unjha Formulations dividend history with payout and yield data.
View Unjha Formulations dividend details including ex-dates and amounts for UNJHAFOR stock.
Unjha Formulations Stock Index Membership
See which indices include Unjha Formulations stock.
Check UNJHAFOR index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Unjha Formulations Market Events Screener - Corporate Actions
Get Unjha Formulations corporate actions including splits, bonuses, and buybacks.
Check Unjha Formulations stock events that may affect UNJHAFOR share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-05-18 | 2026-05-18 | Quarterly Result Announcement | NA | -4.01% |
| 2026-02-04 | 2026-02-04 | Quarterly Result Announcement | NA | -1.25% |
| 2025-11-10 | 2025-11-10 | Quarterly Result Announcement | NA | -2.76% |
| 2025-08-13 | 2025-08-13 | Annual General Meeting | NA | 2.42% |
| 2025-08-06 | 2025-08-06 | Quarterly Result Announcement | NA | -3.52% |
| 2025-05-16 | 2025-05-16 | Quarterly Result Announcement | NA | -1.32% |
| 2025-02-04 | 2025-02-04 | Quarterly Result Announcement | NA | -2.81% |
| 2024-11-08 | 2024-11-08 | Quarterly Result Announcement | NA | 12.80% |
| 2024-08-16 | 2024-08-16 | Annual General Meeting | NA | 12.61% |
Unjha Formulations Competitors Screener - Peer Comparison
Screen UNJHAFOR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 449,827 | 38.82 | 58,220 | 6.38% | 11,565 | 65.03 |
| Divis Laboratories | 174,081 | 69.38 | 10,560 | 8.73% | 2,520 | 43.32 |
| Torrent Pharmaceuticals | 157,634 | 71.51 | 13,886 | 20.34% | 2,138 | 66.05 |
| Cipla | 117,459 | 30.13 | 29,045 | 2.24% | 3,870 | 68.02 |
| Dr Reddys Laboratories | 114,822 | 27.10 | 33,593 | -0.44% | 3,998 | 73.77 |
| Zydus Life Science | 112,829 | 21.63 | 26,720 | 13.65% | 5,242 | 66.06 |
| Lupin | 110,115 | 20.00 | 27,488 | 19.98% | 5,345 | 66.98 |
| Mankind Pharma | 102,623 | 52.44 | 14,278 | 12.03% | 1,750 | 59.48 |
| Aurobindo Pharma | 89,879 | 25.78 | 33,385 | 3.21% | 3,376 | 65.10 |
| Laurus Labs | 80,995 | 88.02 | 6,868 | 22.01% | 890 | 70.64 |
Unjha Formulations Company Announcements - News Screener
Screen UNJHAFOR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-06-29 | Annual Large Corporate Disclosure | - |
| 2026-06-01 | Outcome Of Board Meeting - Appointment Of Company Secretary And Compliance Officer. | - |
| 2026-05-20 | Publish Audited Financial Results For The Quarter And Year Ended As On 31/03/2026 | - |
| 2026-05-20 | Publish Audited Financial Results For The Quarter And Year Ended As On 31/03/2026 | - |
| 2026-05-18 | INTEGRATED FILING(FIN) FOR THE QUARTER AND YEAR ENDED 31/03/2026 | - |
| 2026-05-18 | Board Meeting Outcome for APPROVAL OF AUDITED FR FOR QUARTER AND YEAR ENDED AS ON 31.03.2026 | - |
| 2026-05-07 | Declaration With Respect To Non-Applicability Of Large Corporate Framework Pursuant To SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 Dated November 26 2018 | - |
| 2026-05-07 | Declaration With Respect To Non-Applicability Of Large Corporate Framework Pursuant To SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 Dated November 26 2018 | - |
| 2026-04-22 | Board Meeting Intimation for Board Meeting - Date: 18.05.2026 (AUDITED FINANCIAL RESULTS AS ON 31/03/2026) | - |
| 2026-04-10 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-04-02 | Disclosures Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011. | - |
| 2026-04-02 | Disclosures Under Regulation 30(1) And 30(2) Of SEBI (Substantial Acquisition Of Shares &Takeovers) Regulations 2011 | - |
| 2026-04-02 | Closure of Trading Window | - |
| 2026-02-05 | :Publish Un-Audited Financial Results For The Quarter & Nine Month Ended As On 31/12/2025 | - |
| 2026-02-04 | Approval Of Un-Audited Financial Results Of The Company For 9 Month And Quarter Ended On 31St December2025 And Out Come Of Board Meeting Held On 4Th February 2025. | - |
| 2026-02-04 | Board Meeting Outcome for Approval Of Un-Audited Financial Results Of The Company For 9 Month And Quarter Ended On 31St December2025 And Out Come Of Board Meeting Held On 4Th February 2025. | - |
| 2026-01-20 | Board Meeting Intimation for Board Meeting - Date: 04.02.2026 (Un-Audited Financial Results For The Ninth Month Ended On 31.12.2025) | - |
| 2026-01-12 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-11-12 | Publish Un-Audited Financial Results For The Quarter & Half Year Ended As On 30/09/2025 | - |
| 2025-11-10 | Approval Of Un-Audited Financial Results Of The Company For Quarter Ended And Half Year Ended On 30Th September2025 And Out Come Of Board Meeting Held On 10Th November 2025 | - |